Announcement under Regulation 30 (LODR)-Press Release / Media Release
Cadila Healthcare acquires 51% stake in Windlas Healthcare13-08-2018
13-08-2018
Announcement under Regulation 30 (LODR)-Acquisition
The Company has entered into an agreement to invest in the equity shares of Windlass Healthcare Private Limited (Windlass), for acquiring 51% share capital of Windlass. The details as required under regulation 30 of the SEBI Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is annexed at Annexure A to this letter.13-08-2018
Results For The Quarter Ended On June 30, 2018.
Results for the quarter ended on June 30, 2018.13-08-2018
Outcome of Board Meeting
Un-audited Financial Results for the quarter ended on June 30, 2018 along with limited review report of the Statutory Auditors and the press release in this regard.13-08-2018
Tata, Dabur among suitors selected for Kraft Heinz's $1 billion India sale: report
The Kraft Heinz India sale has also drawn interest from an arm of Cadila Healthcare and other potential buyers03-08-2018
Zydus Cadila gets USFDA nod for anti-bacterial drug
Zydus Cadila has received final approval from the US health regulator to market Azithromycin for Oral Suspension USP, used to treat bacterial infecti01-08-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company has planned investor interaction through a conference call on August 13, 2018 at 5:00 p.m., post announcement of unaudited financial results for the quarter ended on June 30, 2018.01-08-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Azithromycin for Oral Suspension USP01-08-2018
Zydus Cadila gets USFDA nod to market Vardenafil tablets
Zydus Cadila has received tentative approval from the US health regulator to market Vardenafil Hydrochloride tablets used for the treatment of erect30-07-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives tentative approval from the USFDA for Vardenafil Hydrochloride Tablets USP30-07-2018